Cargando…
Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential
The tumour microenvironment is believed to be involved in development, growth, metastasis, and therapy resistance of many cancers. Here we show survivin, a member of the inhibitor of apoptosis protein (IAP) family, implicated in apoptosis inhibition and the regulation of mitosis in cancer cells, exi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669990/ https://www.ncbi.nlm.nih.gov/pubmed/19293795 http://dx.doi.org/10.1038/sj.bjc.6604978 |
_version_ | 1782166290902810624 |
---|---|
author | Khan, S Aspe, J R Asumen, M G Almaguel, F Odumosu, O Acevedo-Martinez, S De Leon, M Langridge, W H R Wall, N R |
author_facet | Khan, S Aspe, J R Asumen, M G Almaguel, F Odumosu, O Acevedo-Martinez, S De Leon, M Langridge, W H R Wall, N R |
author_sort | Khan, S |
collection | PubMed |
description | The tumour microenvironment is believed to be involved in development, growth, metastasis, and therapy resistance of many cancers. Here we show survivin, a member of the inhibitor of apoptosis protein (IAP) family, implicated in apoptosis inhibition and the regulation of mitosis in cancer cells, exists in a novel extracellular pool in tumour cells. Furthermore, we have constructed stable cell lines that provide the extracellular pool with either wild-type survivin (Surv-WT) or the previously described dominant-negative mutant survivin (Surv-T34A), which has proven pro-apoptotic effects in cancer cells but not in normal proliferating cells. Cancer cells grown in conditioned medium (CM) taken from Surv-WT cells absorbed survivin and experienced enhanced protection against genotoxic stresses. These cells also exhibited an increased replicative and metastatic potential, suggesting that survivin in the tumour microenvironment may be directly associated with malignant progression, further supporting survivin's function in tumourigenesis. Alternatively, cancer cells grown in CM taken from the Surv-T34A cells began to apoptose through a caspase-2- and caspase-9-dependent pathway that was further enhanced by the addition of other chemo- and radiotherapeutic modalities. Together our findings suggest a novel microenvironmental function for survivin in the control of cancer aggressiveness and spread, and should result in the genesis of additional cancer treatment modalities. |
format | Text |
id | pubmed-2669990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-26699902010-04-07 Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential Khan, S Aspe, J R Asumen, M G Almaguel, F Odumosu, O Acevedo-Martinez, S De Leon, M Langridge, W H R Wall, N R Br J Cancer Translational Therapeutics The tumour microenvironment is believed to be involved in development, growth, metastasis, and therapy resistance of many cancers. Here we show survivin, a member of the inhibitor of apoptosis protein (IAP) family, implicated in apoptosis inhibition and the regulation of mitosis in cancer cells, exists in a novel extracellular pool in tumour cells. Furthermore, we have constructed stable cell lines that provide the extracellular pool with either wild-type survivin (Surv-WT) or the previously described dominant-negative mutant survivin (Surv-T34A), which has proven pro-apoptotic effects in cancer cells but not in normal proliferating cells. Cancer cells grown in conditioned medium (CM) taken from Surv-WT cells absorbed survivin and experienced enhanced protection against genotoxic stresses. These cells also exhibited an increased replicative and metastatic potential, suggesting that survivin in the tumour microenvironment may be directly associated with malignant progression, further supporting survivin's function in tumourigenesis. Alternatively, cancer cells grown in CM taken from the Surv-T34A cells began to apoptose through a caspase-2- and caspase-9-dependent pathway that was further enhanced by the addition of other chemo- and radiotherapeutic modalities. Together our findings suggest a novel microenvironmental function for survivin in the control of cancer aggressiveness and spread, and should result in the genesis of additional cancer treatment modalities. Nature Publishing Group 2009-04-07 2009-03-17 /pmc/articles/PMC2669990/ /pubmed/19293795 http://dx.doi.org/10.1038/sj.bjc.6604978 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Translational Therapeutics Khan, S Aspe, J R Asumen, M G Almaguel, F Odumosu, O Acevedo-Martinez, S De Leon, M Langridge, W H R Wall, N R Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential |
title | Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential |
title_full | Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential |
title_fullStr | Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential |
title_full_unstemmed | Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential |
title_short | Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential |
title_sort | extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential |
topic | Translational Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669990/ https://www.ncbi.nlm.nih.gov/pubmed/19293795 http://dx.doi.org/10.1038/sj.bjc.6604978 |
work_keys_str_mv | AT khans extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential AT aspejr extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential AT asumenmg extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential AT almaguelf extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential AT odumosuo extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential AT acevedomartinezs extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential AT deleonm extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential AT langridgewhr extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential AT wallnr extracellularcellpermeablesurvivininhibitsapoptosiswhilepromotingproliferativeandmetastaticpotential |